HTRS Hosts Webinar: Novel Therapies In VWD And Rare Bleeding Disorders
Hemostasis & Thrombosis Research Society (HTRS) posted on LinkedIn:
”Join HTRS for our upcoming educational webinar: “Novel Therapies in VWD and Rare Bleeding Disorders” on Tuesday, October 21 at 3:00PM EST.
Discover the latest advances in treatment and research for von Willebrand disease (VWD) and rare bleeding disorders with two renowned experts:
Dr. Debbie Jiang – Adult classical hematologist at Massachusetts General Hospital and the Boston Bleeding Disorders Center. A recipient of the HTRS/Novo Nordisk Clinical Scholar Award, Dr. Jiang is dedicated to advancing care and research for bleeding and clotting disorders.
Dr. Stacy Croteau – Pediatric hematologist and clinical researcher at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. As Medical Director of the Boston Bleeding Disorders Center and National Chair of the ATHN/NHPCC Transition Working Group, Dr. Croteau leads efforts to improve outcomes and transitions of care for individuals with bleeding disorders.
Don’t miss this opportunity to hear directly from leaders shaping the future of bleeding disorder care. Register now to secure your spot.”
Stay updated with Hemostasis Today.
-
Jan 29, 2026, 14:02Emma Lefrancais on Alarmin IL33 and Platelet Biology
-
Jan 29, 2026, 13:44Sia A: One of My Favorite Conversations from ASH
-
Jan 29, 2026, 13:34Sarah Matuja on Tanzania Stroke Project
-
Jan 29, 2026, 13:28Nancy Di Salvo on Amplifying Rare Disease Voices Through Partnership
-
Jan 29, 2026, 13:21Raul Santos Shares The Results of ORION-16: On The Efficacy and Safety of Inclisiran
-
Jan 29, 2026, 05:22Aravind Palraj Draws a Comparison Between APS and Lupus Cerebritis
-
Jan 29, 2026, 05:09Edina Cenko on Expanding Cardiovascular Risk: From Ischaemia to Emerging Frontiers
-
Jan 29, 2026, 04:58Anna Randi Shares the Latest Episode of The VWF and Angiogenesis Story from Her Lab
-
Jan 29, 2026, 04:49Ruah Alyamany on Her Contribution to Establishing The Role of IgM in APS